<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02006797</url>
  </required_header>
  <id_info>
    <org_study_id>PREPS12-XP/REPHVIM</org_study_id>
    <nct_id>NCT02006797</nct_id>
  </id_info>
  <brief_title>Communication Between Hospital and Community Pharmacists: Impact on Drug Management at Discharge</brief_title>
  <acronym>REPHVIM</acronym>
  <official_title>Impact of Drug Reconciliation at Discharge and Pharmaceutical Communication Between Hospital and Community Pharmacists on Drug Related Problems: Study Protocol for a Cluster Randomized Cross-over Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the impact of a communication between hospital pharmacist and
      community pharmacists in addition to drugs reconciliation procedure at discharge. It will be
      conducted in 21 french public hospitals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transition points during hospitalization are at risk of drug related problems (DRP)
      especially admission and discharge. Reconciliation procedure at admission lead by a clinical
      pharmacist had been proved to decrease DRP. The community pharmacist (CP) is often the first
      health professional that patients meet at discharge. He/she is in charge of dispensing their
      medication to patients and give treatment information. However because of lack of information
      community pharmacist is not always able to identify problems and this may lead to dispense
      wrong drugs and/or wrong dosage and/or give wrong information. The objective of this study is
      to assess the impact of drug reconciliation performed at discharge completed by a
      communication between the Hospital Pharmacist (HP) and community pharmacist on drug related
      problem during the 7 days following discharge at home.

      The study is a cluster randomized cross-over trial. It involves 21 French universitarian and
      non-universitarian hospitals with 42 care units: 22 medical units and 20 surgical units. Each
      unit (a unit corresponds to a cluster) is involved during two consecutive 14-day periods
      which are randomly assigned as &quot;experimental&quot; or &quot;control&quot; where control corresponds to usual
      care. During the experimental period, for each eligible patient discharged during the period,
      a reconciliation procedure will be performed by the HP, with communication to the patient.
      The HP will further inform the patient's community pharmacist about patient's drug therapy
      [modification in home medication, acute drugs prescribed, shelved treatments and/or labs
      results to survey patient]. Eligible patients will be over 18, attending to the same
      community pharmacist for at least 3 months. We will exclude patients with a length stay over
      21 days (too many therapeutic modifications), those who do not return to home, and also
      palliative patient. The primary outcome is a composite outcome associating any kind of drug
      misuse during the 7 days following discharge. It will be assessed by phone at day 7 (+/-2) by
      a pharmacist in charge of the study (PCS) will phone both patients and community pharmacists
      . The secondary outcome will be the unplanned hospitalizations observed in each group
      assessed by phone at day 35 (+/-5). We plan to recruit 1,176 patients, i.e. 14 per period per
      unit.

      This study will assess the impact of a reconciliation procedure at discharge followed by a
      communication between HP and community pharmacists . Also it will identify the type of
      patients for which the intervention is the most relevant in France and may be generalized to
      other countries that have the same care organisation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>drug related problems (DRP)</measure>
    <time_frame>7 days after patient discharge</time_frame>
    <description>The primary outcome is a composite endpoint associated all the problems/dysfunctions that can be observed from the hospital to home during 7 days after discharge. We will be taking in account the occurence of a dysfunction every time that one of the following problems will happen: - first drug problem; the drug taken by the patient has a problem: it is not the right medicine (Name, form, route, dose). The fault may be 1) an error between the processing of transcription at the admission and the discharge, 2) a therapeutic modification related to therapeutic formulary restriction, the home medication is replaced by an another one that may be less adaptated to patient, 3) an error linked to the writing. Second : patient due to patient; the patient doesn't take what was prescribed and / or treatments that he takes are stopped. Third- :presence of a gap in the continuity and duration of therapy: the patient could not have his medication when he's coming at the pharmacy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>all compounds of the composite primary outcome measure (patient errors, medical error and DRP)</measure>
    <time_frame>day 7 after discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinical impact of problems</measure>
    <time_frame>days 7 after discharge</time_frame>
    <description>all problems will be scored of the potential iatrogenic impact (from 0: none to 3: fatal) by a team associated a nephrologist, a cardiologist, a gastroenterologist and a clinical pharmacist.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of non-planned hospitalization</measure>
    <time_frame>days 35 after discharge</time_frame>
    <description>number of non-planned hospitalizations in each group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>day 7 after patient discharge</time_frame>
    <description>the patient will have to tell his satisfaction about his drugs management by health professionals at discharge. It will be evaluated by a Likert scale with 4 items.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>community pharmacist satisfaction about exchanges with hospital pharmacists</measure>
    <time_frame>7 days after patient discharge</time_frame>
    <description>the community pharmacist will have to tell his satisfaction about his drugs management by health professionals at discharge. It will be evaluated by a Likert scale with 4 items.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time spend by hospital pharmacist on reconciliation and communication to community pharmacist</measure>
    <time_frame>at day 2/3 after discharge</time_frame>
    <description>the hospital pharmacist will notice the time spent to patient reconciliation and communicate informations to community pharmacist. Time will be those declared by the hospital pharmacist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentage of drugs prescription modified by the hospital pharmacist at discharge</measure>
    <time_frame>at discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1176</enrollment>
  <condition>Treatment Error</condition>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with reconciliation procedure at discharge and included in the exchange process</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>reconciliation</intervention_name>
    <description>medication reconciliation at discharge and communication of this intervention to patient's community pharmacist</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients over 18

          -  patients attending to the same CP for at least 3 months

          -  patients speaking french

        Exclusion Criteria:

          -  patients with a length stay over 21 days (too many therapeutic modifications),

          -  patients who do not return to home,

          -  palliative patients and/or expected end of life

          -  patients that will not give their informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier POURRAT, Pr</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Régional Universitaire de Tours</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier POURRAT, Pr</last_name>
    <phone>+33(2)34389539</phone>
    <email>X.POURRAT@chu-tours.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Alès-Cévennes</name>
      <address>
        <city>Ales</city>
        <zip>30100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent BOUIX</last_name>
      <phone>+33(0)466783147</phone>
      <email>vbouix@ch-ales.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent BOUIX</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric MOAL</last_name>
      <phone>+33(0)241354956</phone>
      <email>frmoal@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Frédéric MOAL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Bethune</city>
        <zip>62408</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine FLORET</last_name>
      <phone>+33(0)321644133</phone>
      <email>cfloret@ch-bethune.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine FLORET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Blois</city>
        <zip>41000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mathilde EMONET</last_name>
      <phone>+33(0)254556633</phone>
      <email>emonetm@ch-blois.fr</email>
    </contact>
    <investigator>
      <last_name>Mathilde EMONET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de la Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maud PERENNES</last_name>
      <phone>+33(0)298347600</phone>
      <email>maud.perennes@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Maud PERENNES</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital ESTAING</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne BOYER</last_name>
      <phone>+33(0)473357911</phone>
      <email>aboyer@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Anne BOYER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopitaux civils de Colmar</name>
      <address>
        <city>Colmar</city>
        <zip>68000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christelle LEMARIGNIER</last_name>
      <phone>+33(0)389124240</phone>
      <email>christelle.lemarignier@ch-colmar.fr</email>
    </contact>
    <investigator>
      <last_name>Christelle LEMARIGNIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Compiègne-Noyon</name>
      <address>
        <city>Compiegne</city>
        <zip>60200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne-Marie LIEBBE</last_name>
      <phone>+33(0)344236465</phone>
      <email>am.liebbe@ch-compiegnenoyon.fr</email>
    </contact>
    <investigator>
      <last_name>Anne-Marie LIEBBE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierrick BEDOUCH</last_name>
      <phone>+33(0)476765496</phone>
      <email>pbedouch@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Pierrick BEDOUCH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Jacques Monod</name>
      <address>
        <city>Le Havre</city>
        <zip>76290</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dorothée LAURE-OLIVIER</last_name>
      <phone>+33(0)2 32 73 33 90</phone>
      <email>dorothee.olivier@ch-havre.fr</email>
    </contact>
    <investigator>
      <last_name>Dorothée LAURE-OLIVIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne-marie CAMINONDO</last_name>
      <phone>+33(0)243432846</phone>
      <email>amcaminondo@ch-lemans.fr</email>
    </contact>
    <investigator>
      <last_name>Anne-Marie CAMINONDO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Conception</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe MONGES</last_name>
      <phone>+33(0)491383935</phone>
      <email>Philippe.MONGES@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe MONGES</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de Mercy Metz-Thionville</name>
      <address>
        <city>Metz</city>
        <zip>57085</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Grégory RONDELOT</last_name>
      <phone>+33(0)387553484</phone>
      <email>g.rondelot@chr-metz-thionville.fr</email>
    </contact>
    <investigator>
      <last_name>Grégory RONDELOT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Pierre Bérégovoy</name>
      <address>
        <city>Nevers</city>
        <zip>58000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie-Odette TISSERON-GUYOT</last_name>
      <phone>+33(0)386937086</phone>
      <email>marieodette.tisseron@ch-nevers.fr</email>
    </contact>
    <investigator>
      <last_name>Marie-Odette TISSERON-GUYOT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Archet</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rémy COLLOMP</last_name>
      <phone>+33(0)492039281</phone>
      <email>COLLOMP.R@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Rémy COLLOMP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Nimes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clarisse ROUX</last_name>
      <phone>+33(0)466683739</phone>
      <email>clarisse.roux@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Clarisse ROUX</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sophie SURY-LESTAGE</last_name>
      <phone>+33(0)549443801</phone>
      <email>sophie.SURY-LESTAGE@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Sophie SURY-LESTAGE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Inter Armées</name>
      <address>
        <city>Saint Mande</city>
        <zip>94160</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Virginie LAMAND</last_name>
      <phone>+33(0)143985038</phone>
      <email>lamand.virginie@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Virginie LAMAND</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bénédicte GOURIEUX</last_name>
      <phone>+33(0)388127803</phone>
      <email>benedicte.gourieux@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Bénédicte GOURIEUX</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cécile LEBAUDY</last_name>
      <phone>+33(0)561776418</phone>
      <email>lebaudy.c@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile LEBAUDY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier POURRAT</last_name>
      <phone>+33(0)234389539</phone>
      <email>x.pourrat@chu-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Xavier POURRAT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2013</study_first_submitted>
  <study_first_submitted_qc>December 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2013</study_first_posted>
  <last_update_submitted>January 23, 2014</last_update_submitted>
  <last_update_submitted_qc>January 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>reconciliation</keyword>
  <keyword>discharge</keyword>
  <keyword>pharmacist</keyword>
  <keyword>drug related problems</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

